AGP Picks
View all

Middle East Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.

Press releases published on March 4, 2026

Team 7 Consulting Announces AIDA™, an Autonomous AI System for Monitoring, Securing, and Managing Modern Datacenters
Strategic Super Reserve ($SSR) Migrates to PumpSwap via Migrate.fun and Joins Pump.fun Build-In-Public Hackathon
M2MMA Appoints Former ABC President Michael Mazzulli to Advisory Board as M2Intel AI Platform Advances
Squaretalk Partners with CCSA to Strengthen CX and Outsourcing Capabilities Across Africa
Xtract One Announces Fiscal 2026 Second Quarter Results
The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome
Actuate Therapeutics to Present at The Citizens Life Sciences Conference
DBV Technologies to Participate in Upcoming March Investor Conferences
DBV Technologies annonce sa participation à plusieurs conférences investisseurs en mars
SCYNEXIS Reports Full Year 2025 Financial Results and Provides Corporate Update
Castellum, Inc. Announces 2025 Unaudited Financial Results
Pulmonx Reports Fourth Quarter and Full Year 2025 Financial Results
LB Pharmaceuticals to Participate in Upcoming March Investor Events
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Rigetti Computing Reports Fourth Quarter and Full-Year 2025 Financial Results
red violet Announces Fourth Quarter and Full Year 2025 Financial Results
Pulmonx Announces Closing of up to $60 Million Credit Facility
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025
BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance
Larimar Therapeutics to Participate in Upcoming Investor Conferences in March

Share this page:

Sign up for:

Middle East Tech Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.